Pacific Shuanglin Bio-pharmacy Co., LTD (SHE: 000403)
China flag China · Delayed Price · Currency is CNY
22.67
+0.01 (0.04%)
Nov 15, 2024, 11:48 AM CST

Pacific Shuanglin Bio-pharmacy Co., LTD Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Sep '24 Dec '23 Jan '23 Jan '22 Jan '21 Jan '20 2019 - 2015
Net Income
828.65612.11587.13391.06185.97160.45
Upgrade
Depreciation & Amortization
142.74142.74126.39115.7647.3746.3
Upgrade
Other Amortization
3.373.374.437.398.368.5
Upgrade
Loss (Gain) From Sale of Assets
0.540.54-0.44-0.27-0.020.36
Upgrade
Asset Writedown & Restructuring Costs
1.291.293.59103.675.272.52
Upgrade
Loss (Gain) From Sale of Investments
-17.56-17.56-7.97-77.91--6.65
Upgrade
Provision & Write-off of Bad Debts
-2.04-2.049.669.44-3.697.59
Upgrade
Other Operating Activities
-229.69-14.95-38.62-33.92-1.2419.1
Upgrade
Change in Accounts Receivable
274.65274.65-329.07-196.58-89.04-125.84
Upgrade
Change in Inventory
-285.42-285.42115.511.72-37.11-17.22
Upgrade
Change in Accounts Payable
-31.26-31.2670.9470.0657.6296.39
Upgrade
Change in Other Net Operating Assets
2.232.2310.621.6522.44-
Upgrade
Operating Cash Flow
680.81679.01524.22408.22194.84190.84
Upgrade
Operating Cash Flow Growth
43.89%29.53%28.42%109.51%2.09%63.62%
Upgrade
Capital Expenditures
-369.47-377.27-378.64-326.16-40.18-41.11
Upgrade
Sale of Property, Plant & Equipment
1.771.650.451.350.091.32
Upgrade
Cash Acquisitions
---64.57--
Upgrade
Investment in Securities
-336.216.66-259.36-160--
Upgrade
Other Investing Activities
45.8569.7581.18-258.03-262.7110
Upgrade
Investing Cash Flow
-658.05-289.21-556.38-678.28-302.81-29.8
Upgrade
Long-Term Debt Issued
-438.32481.79303.16477.069.84
Upgrade
Total Debt Issued
410.36438.32481.79303.16477.069.84
Upgrade
Long-Term Debt Repaid
--316.89-263.4-833.63-235-70
Upgrade
Total Debt Repaid
-320.55-316.89-263.4-833.63-235-70
Upgrade
Net Debt Issued (Repaid)
89.8121.43218.39-530.47242.06-60.16
Upgrade
Issuance of Common Stock
16.388.32.511,59735.2-
Upgrade
Repurchase of Common Stock
-24.23-24.23-21.98---
Upgrade
Common Dividends Paid
-158.33-66.79-49.66-12.05-178.84-144.61
Upgrade
Other Financing Activities
25.51-0.47-0.81.76-1.76-
Upgrade
Financing Cash Flow
-50.8738.24148.461,05696.66-204.77
Upgrade
Foreign Exchange Rate Adjustments
-0.11-0.02-1.19-0.23--
Upgrade
Net Cash Flow
-28.22428.01115.11785.52-11.31-43.72
Upgrade
Free Cash Flow
311.34301.74145.5882.06154.66149.73
Upgrade
Free Cash Flow Growth
708.72%107.27%77.40%-46.94%3.29%83.46%
Upgrade
Free Cash Flow Margin
10.95%12.96%6.05%4.16%14.73%16.35%
Upgrade
Free Cash Flow Per Share
0.430.410.200.120.320.31
Upgrade
Cash Interest Paid
-----144.61
Upgrade
Cash Income Tax Paid
238.61213.87172148.9271.8769.67
Upgrade
Levered Free Cash Flow
185.23186.77-7.27-289.4536.62-105.84
Upgrade
Unlevered Free Cash Flow
192.18192.790.25-282.7148.69-92.27
Upgrade
Change in Net Working Capital
151.37-25.66127.58365.67124.13225.25
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.